Price$85.02+0.24 (+0.28%)
01:30 PM07:45 PM
News · 26 weeks95+157%
2025-12-072026-05-31
Mix4990d
- Insider29(59%)
- SEC Filings8(16%)
- Other8(16%)
- Earnings2(4%)
- Analyst1(2%)
- Leadership1(2%)
Latest news
25 items- INSIDERSEC Form 4 filed by Officer Noor Jehanzeb4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERGroup President, Asia Pacific Yi Sang sold $413,216 worth of shares (5,000 units at $82.64), decreasing direct ownership by 16% to 27,251 units (SEC Form 4)4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- PRZimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare ConferenceWARSAW, Ind., June 2, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8 with a fireside chat at 10:40 a.m. ET. A live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the fireside chat.About Zimmer BiometZimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize
- SECZimmer Biomet Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Filer)
- SECSEC Form SD filed by Zimmer Biomet Holdings Inc.SD - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Filer)
- INSIDERSEC Form 4 filed by Director Farrell Michael J.4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Bernard Betsy J4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Hilado Maria Teresa4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Shapiro Louis4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Kurdikar Devdatt4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Kolli Sreelakshmi4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Jafry Syed A.4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Higgins Arthur J4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Hagemann Robert4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- PRZimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026WARSAW, Ind., May 22, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2026. The cash dividend of $0.24 per share is payable on or about July 31, 2026 to stockholders of record as of the close of business on June 25, 2026. About Zimmer BiometZimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessl
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Zimmer Biomet Holdings Inc.SCHEDULE 13G/A - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Subject)
- SECZimmer Biomet Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Leadership Update, Financial Statements and Exhibits8-K - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Filer)
- PRZimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year EndWARSAW, Ind., May 12, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it now anticipates repurchasing up to $1 billion of its common stock during fiscal year 2026, a $250 million increase from the company's prior assumption. All repurchases are expected to be made under the company's existing $1.5 billion share repurchase authorization, which was approved by the Zimmer Biomet Board of Directors and announced in February 2026. The company has not made any changes to the size, duration or terms of that
- PRZimmer Biomet to Present at the BofA Securities 2026 Health Care ConferenceWARSAW, Ind., May 6, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will participate in the Bank of America Securities Health Care Conference on Wednesday, May 13, 2026, with a fireside chat at 8:40 a.m. PT (11:40 a.m. ET). A live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the fireside chat.About Zimmer Biomet Zimmer Biomet is a global medical
- INSIDERSEC Form 4 filed by VP, Controller, CAO Stellato Paul A4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- SECSEC Form 10-Q filed by Zimmer Biomet Holdings Inc.10-Q - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Filer)
- SECZimmer Biomet Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure8-K - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Filer)
- SECZimmer Biomet Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Filer)
- PRZimmer Biomet Announces First Quarter 2026 Financial ResultsFirst quarter net sales of $2.087 billion increased 9.3% on a reported basis, 6.8% on a constant currency1 basis and 2.9% on an organic constant currency1 basisFirst quarter diluted earnings per share were $1.22, an increase of 34.1%; adjusted1 diluted earnings per share were $2.09, an increase of 15.5%Company updates full-year 2026 financial guidanceWARSAW, Ind., April 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2026. The Company reported first quarter net sales of $2.087 billion, an increase of 9.3% over the prior year period, an increase of 6.8% on a constant currency1 basis and an increase of
- PRZimmer Biomet Announces Chief Financial Officer TransitionSuketu Upadhyay to Depart; Paul Stellato Named Interim CFOWARSAW, Ind., April 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced Suketu Upadhyay, Chief Financial Officer and Executive Vice President, Finance, Operations and Supply Chain, will depart the company effective April 28 for a new professional opportunity. The company has named Paul Stellato, currently Controller and Chief Accounting Officer, as interim Chief Financial Officer, while the company conducts an internal and external search to identi
ZBH FAQ
7 questionsWhat does Zimmer Biomet Holdings Inc. do?
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the...Where does ZBH stock trade?
Zimmer Biomet Holdings Inc. (ZBH) is listed on NYSE.What sector and industry is ZBH in?
Zimmer Biomet Holdings Inc. operates in the Health Care sector, Industrial Specialties industry.Does ZBH pay a dividend?
Yes. ZBH's next ex-dividend date is 2026-06-25 with a declared cash dividend of $0.24 per share, payable 2026-07-31.What are analysts saying about ZBH?
Zimmer Biomet Holdings Inc. has had 8 recent analyst actions on file. The most recent action was from BTIG Research: Neutral on 2026-03-23.What companies are similar to ZBH?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), MAS (Masco Corporation), SNN (Smith & Nephew SNATS Inc.). Compare ZBH side-by-side with any of them on Quantisnow.How can I track ZBH on Quantisnow?
Quantisnow aggregates Zimmer Biomet Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ZBH to receive live email and push alerts on every new disclosure.